Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection
NCT ID: NCT05594550
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2022-10-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.
NCT07303335
Assessment of the Prognostic Value of the Thickness of the Quadriceps and Abdominal Muscles Measured by Ultrasound for 28-day Mortality in Postoperative ICU Patients
NCT05276921
Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19
NCT04780126
Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit
NCT02270502
Diaphragmatic Atrophy Related to Mechanical Ventilation
NCT02766946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
28-day survival
Alive 28 days after intensive care admission
Data collection
Demographic data:
Age, Sex, weight, height, main history and treatments.
\- Biological data: CRP, PCT, albumin, pre-albumin
analysis of thoracic scans
muscle area calculated on the T7 and T12 thoracic slices
28-day death
Deceased 28 days after intensive care admission
Data collection
Demographic data:
Age, Sex, weight, height, main history and treatments.
\- Biological data: CRP, PCT, albumin, pre-albumin
analysis of thoracic scans
muscle area calculated on the T7 and T12 thoracic slices
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Demographic data:
Age, Sex, weight, height, main history and treatments.
\- Biological data: CRP, PCT, albumin, pre-albumin
analysis of thoracic scans
muscle area calculated on the T7 and T12 thoracic slices
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Thoracic TDM within the 30 day preceding ICU admission and up to 24 hours after ICU admission
Exclusion Criteria
* Neuromuscular disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NGUYEN 2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.